ClinicalTrials.gg
Drug

Tivozanib clinical trials

Also written AV-951, KRN951 and Fotivda.

studies test it
38
open now
3
in phase 3
5
first study started
2007

How each study uses tivozanib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tivozanib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Mar 2021 · FOTIVDA · NDA 212904 (FDA, Drugs@FDA)
European Union
24 Aug 2017 · Fotivda · EMEA/H/C/004131 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tivozanib
28
Tivozanib hydrochloride
5
Tivozanib (AV-951)
4
oral VEGF receptor tyrosine kinase inhibitor AV-951
3

Brand

Fotivda
2

Development codes

AV-951
15
KRN951
3
UNII-172030934T
1
ASP4130
1

Studies by the year they started

38 studies that test it; most in 2013 (10)

Studies that test tivozanib, by start year
YearStudies
20072
20081
20094
20105
20115
20123
201310
20161
20171
20191
20212
20221
20241
20251

Who runs them

Industry 23 · Other 15

AVEO Pharmaceuticals, Inc. (22) · Dana-Farber Cancer Institute (3) · Northwestern University (2) · Roswell Park Cancer Institute (2) · Massachusetts General Hospital (2) · M.D. Anderson Cancer Center (1) · Kyowa Kirin Co., Ltd. (1) · Alliance for Clinical Trials in Oncology (1)

Often tested with

Tested in the same studies.

Nivolumab (2) · Sorafenib (1) · Atezolizumab (1) · Erlotinib (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test tivozanib.

Studies

Open first, then newest update. How each study uses tivozanib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 38

See all 38 studies that test tivozanib →

Given beside what is tested · 2 — tivozanib is usual care or a partner of the new treatment

Codes

What other systems call tivozanib · ClinicalTrials.gg INT005730

  • MeSH (NLM) C553176tivozanibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 172030934TTIVOZANIBConfirmed FDA, NLM, Wikidata
  • RxNorm 2534233Confirmed FDA, Wikidata
  • Wikidata Q7810457tivozanibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C85444TivozanibOne source FDA
  • DrugBank DB11800One source Wikidata

Also registered as tivozanib hydrochloride (UNII 8A9H4VK35Z · RxNorm 2534245).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.